A detailed history of Toronto Dominion Bank transactions in Guardant Health, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 2,000 shares of GH stock, worth $85,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 48,600 95.88%
Holding current value
$85,740
Previous $1.48 Million 95.89%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 19, 2025

SELL
$20.2 - $38.11 $941,320 - $1.78 Million
-46,600 Reduced 95.88%
2,000 $61,000
Q4 2024

Feb 14, 2025

BUY
$20.2 - $38.11 $981,720 - $1.85 Million
48,600 New
48,600 $1.48 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.38B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.